openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Discover
2026 Elections
Sports
Markets

Sun Pharmaceutical — news, coverage & facts — IJR

|NewsJournalsOrganizationSun Pharmaceutical

Sun Pharmaceutical

Organization

Sun Pharmaceutical

6 members

What's driving coverage of Sun Pharmaceutical right now?

6 members

Comments

Ask this entity anything:

Free account · your comment posts right after signup

Photo: Indian — Wikimedia Commons / Wikimedia Commons
Health
India pharma deals hold steady at $13.9B
Indian pharma and healthcare deal value held at about $13.9 billion in Q1 FY27 and Q2 2026 despite a decline in deal volumes, led by Sun Pharmaceutical Industries’ $11.8 billion acquisition of Organon & Co. and a clear shift toward specialty portfolios, global market access, and differentiated capabilities, with investor interest centering on AI-enabled care, genomics, oncology, and advanced diagnostics, and outbound M&A accounting for the vast majority of activity.
5 sources

Facts from Wikidata (CC0).

Overview

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.

Sun Pharmaceutical across IJR

Ask IJR about Sun Pharmaceutical Create in Studio Build a game Watch videos